Lymphoproliferative disorders after organ transplantation in children

Transplantation

Volumn 67, Issue 7, 1999, Pages 990-998

  Dror, Yigal ^a   Greenberg, Mark ^a   Taylor, Glenn ^a   Superina, Riccardo ^a   Hébert, Diane ^a   West, Lori ^a   Connolly, Bairbre ^a   Sena, Lauri ^a   Allen, Upton ^a   Weitzman, Sheila ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS INFECTION;

ADOLESCENT; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; OLIGONUCLEOTIDES; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREVALENCE;

EID: 0033561025     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904150-00010     Document Type: Article

References (38)

1. Penn I. The price of immunotherapy. Curr Probl Surg 1981; 18: 681.
2. Hoover R, Fraumeni JF. Risk of cancer in renal transplant recipients. Lancet 1973; 2: 55.
3. Opelz G, Henderson R, for the Collaborative Transplant Study: incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514.
4. Magrath IT, Rowe M, Filipovich AH, et al. Advances in understanding of EBV associated lymphoproliferative disorders. In Ablashi DV, ed. EBV and human disease. Clifton, NJ: Human Press, 1991; 243.
5. Harris NL, Ferry JA, Swerdlow SH. Post transplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 1997; 14(1): 8.
6. Morgan G, Superina R. Lymphoproliferative disorders post liver transplant. J Pediatr Surg 1994; 29 (9): 1192.
7. Cockfield SM, Preiksaitis J, Harvey E, et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc 1991; 23: 1106.
8. Houle AM, McLorie GA, Churchill BM, Khoury AE, Harvey E, Hebert D. Rapid development of an immunoblastic lymphoma and death in children following cadaver renal transplantation. J Pediatr Surg 1992; 27: 626.
9. Anonymous. National Cancer Institute sponsored study of classification of non-Hodgkin lymphoma: summary and description of a working formulation for clinical usage; The Non-Hodgkin Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112.
10. Sixby JW, Shirly PS. Viral diagnosis using DNA-based probes: enzymatic amplification of target DNA. NY Acad Sci 1988; 158.
11. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin lymphoma: dissimilarities with lymphomas in adults. Semin Oncol 1980; 7: 332.
12. Miller AB, Hoogstraten B, Staquer M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207.
13. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single institution. J Clin Oncol 1995; 13 (4): 961.
14. Walker RC, Marshall WF, Stickler JG, et al. Pretransplant assessment of the risk of lymphoproliferative disorders. Clin Infect Dis 1995; 20: 1346.
15. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantations in children. Transplantation 1988; 45 (4): 719.
16. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developed after cyclosporine-steroid therapy. Lancet 1984; 1: 583.
17. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increase incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59 (4): 524.
18. Morrison VA, Dunn DL, Manivel JC, et al. Clinical characteristic of post transplant lymphoproliferative disorders. Am J Med 1994; 97: 14.
19. Swerdlow SH. Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semm Diagn Pathol 1997; 14 (1): 2.
20. Wu TT, Swerdlow SH, Locker J, et al. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 1996; 27 (2): 157.
21. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 72 (5): 1234.
22. Nelson BN, Naleznik MA, Locker JD, Swerdlow SH. Posttransplant lymphoproliferative disorders in the adult: the Pittsburgh experience [Abstract]. Mod Pathol 1997; 10 (1): 131A.
23. Chadburn A, Cesarman E, Knowles DM. Classification of posttransplantation lymphoproliferative disorders based on morphologic and molecular genetic features has clinical relevance [Abstract]. Mod Pathol 1997; 10 (1): 121A.
24. Collins MH, Mortone KT, Hodinka RL, et al. Posttransplant lymphoproliferative disorder in children: clinicopathologic correlation of fourteen cases [Abstract], Mod Pathol 1997; 10 (1): 156A.
25. Fisher A, Blanche S, Le Bidois J, et al. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451.
26. Benkerrou M, Durrandy A, Fischer A. Therapy for transplantrelated lymphoproliferative disease. Hematol Oncol Clin North Am 1993; 7 (2): 467.
27. Swinnen LJ, Mullen GM, Carr TJ, et al. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86 (9): 3333.
28. Hanto DW, Fizzera KJ, Gajl-Peczalska, et al. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 1985; 17 (1): 89.
29. Pirsch JD, Stratta RJ, Sollinger HW, et al. Treatment of Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. Am J Med 1989; 86: 241.
30. Delone P, Corkill J, Jordan M, et al. Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation. Transplant Proc 1995; 27 (5) (Suppl 1): 58.
31. Oettle H, Wilborn F, Schmidt CA, et al. Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation. Blood 1993; 82 (7): 2257.
32. Dellemijn PLI, Brandenburg A, Niesters HGM, et al. Successful treatment with ganciclovir of presumed Epstein-Barr meningoencephalitis following bone marrow transplant. Bone Marrow Transplant 1995; 16: 311.
33. Shapiro RS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with Interferon alpha and intravenous gamma globulin. N Engl J Med 1988; 318: 1334.
34. Gallen-Melcon S, De Toledo JS, Martinez V, et al. Non-Hodgkin lymphoma after liver transplantation: response to chemotherapy. Med Pediatr Oncol 1996; 27: 156.
35. Nalesnick MA, Makowka L, Starzl TE. The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg 1988; 25: 365.
36. Cohen J Epstein-Barr virus lymphoproliferative disease. Medicine 1991; 70: 137.
37. Blanche S, Le Deist F, Veber F, et al. Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Ann Intern Med 1988; 108: 199.
38. Lazarovits AI, Tibbles LA, Grant DR, et al. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation. Clin Invest Med 1994; 17 (6): 621.